A wearable hemofilter for continuous ambulatory ultrafiltration

Kidney International

Volumn 73, Issue 4, 2008, Pages 497-502

  Gura, V ^a   Ronco, C ^b   Nalesso, F ^b   Brendolan, A ^b   Beizai, M ^c   Ezon, C ^c   Davenport, A ^d   Rambod, E ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN BORTOLO HOSPITAL   (Italy)

^c Xcorporeal Inc   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e BioQuantetics Inc   (United States)

Author keywords

Congestive cardiac failure; CRRT; Fluid overload; Ultrafiltration; Wearable hemofiltration device

Indexed keywords

HEPARIN; SODIUM;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BIOFILTER; BLOOD CLOTTING; BLOOD PRESSURE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; DIALYSIS CATHETER; FEMALE; HEART FAILURE; HEMOLYSIS; HUMAN; MALE; MINIPUMP; PATIENT SAFETY; PRIORITY JOURNAL; PULSE RATE; QUALITY OF LIFE; SODIUM EXCRETION; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 38749137748     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002711     Document Type: Article

References (34)

1. Lewis CE, Jacobs Jr DR, McCreath H et al. Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 2000; 151: 1172-1181.
2. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 1387-1393.
3. Gottdiener JS, McClelland RL, Marshall R et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002; 137: 631-639.
4. American Heart Association. Heart Disease and Stroke Statistics - 2007 Update.
5. Krumholz HM, Parent EM, Tu N et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99-104.
6. Stevenson LW. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Fail 1999; 1: 251-257.
7. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002; 287: 628-640.
8. Fonarow GC. Pharmacologic therapies for acutely decompensated heart failure. Rev Cardiovasc Med 2002; 3(Suppl 4): S18-S27.
9. Blake P, Hasegawa Y, Khosla MC et al. Isolation of 'myocardial depressant factor(s)' from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 1996; 42: M911-M915.
10. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-585.
11. Levine B, Kalman J, Mayer L et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
12. Brater DC. Diuretic therapy. N Engl J Med 1998; 339: 387-395.
13. Neuberg GW, Miller AB, O'Connor CM et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002; 144: 31-38.
14. Cairns KB, Porter GA, Kloster FE et al. Clinical and hemodynamic results of peritoneal dialysis for severe cardiac failure with chronic edema. Am Heart J 1968; 76: 227-234.
15. Hampl H, Paeprer H, Unger V et al. Hemodynamic changes during hemodialysis sequential ultrafiltration and hemofiltration. Kidney Int 1980; 18: S83-S88.
16. Silverstein ME, Ford CA, Lysaght MJ et al. Treatment of severe fluid overload by ultrafiltration. N Engl J Med 1974; 291: 747-751.
17. Kramer P, Wigger W, Rieger J et al. Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics (in German). Klin Wochenschr 1977; 55: 1121-1122.
18. Donato L, Biagini A, Contini C et al. Treatment of end-stage congestive heart failure by extracorporeal ultrafiltration. Am J Cardiol 1987; 59: 379-380.
19. Blake P, Paganini EP. Refractory congestive heart failure, overview and application of extracorporeal ultrafiltration. Adv Ren Replace Ther 1996; 3: 166-173.
20. Ronco C, Riccci Z, Bellomo R, Bedogni F. Extracorporeal ultrafiltration for the treatment of over hydration and congestive heart failure. Cardiology 2002; 96: 155-168.
21. Sheppard R, Panyon J, Pohwani AL et al. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 2004; 10: 380-383.
22. Clark WR, Paganini E, Weinstein D et al. Extracorporeal ultrafiltration for acute exacerbations of chronic heart failure: report from the Acute Dialysis Quality Initiative. Int J Artif Organs 2005; 28: 466-476.
23. Simpson IA, Rae AP, Simpson K et al. Ultrafiltration in the management of refractory congestive heart failure. Br Heart J 1986; 55: 344-347.
24. Stephens RL, Jacobsen SC, Atkin-Thor E, Kolff W. Portable/wearable artificial kidney (WAK) - initial evaluation. Proc Eur Dial Transplant Assoc 1976; 12: 511-518.
25. Gura V, Beizai M, Ezon C, Polaschegg HD. Continuous renal replacement therapy for end-stage renal disease: the wearable artificial kidney (WAK). Contrib Nephrol 2005; 149: 325-333.
26. Gura V, Beizai M, Ezon C, Rambod E. Continuous renal replacement therapy for congestive heart failure: the wearable continuous ultrafiltration system. ASAIO J 2006; 52: 59-61.
27. Nissenson AR, Ronco C, Pergamit G et al. Continuously functioning artificial nephron system: the promise of nanotechnology. Hemodial Int 2005; 9: 210-217.
28. Francis GS, Siegel RM, Goldsmith SR et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis. Ann Intern Med 1985; 103: 1-6.
29. Agostoni P, Marenzi G, Lauri G et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994; 96: 191-199.
30. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999; 138: 285-290.
31. Hillege HL, Girbes ARJ, de Kam PJ et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210.
32. ADHERE Registry. Acute Decompensated Heart Failure National Registry. Q1 2004 National Benchmark Report. Adair-Greene Healthcare Communications: Atlanta, GA, 2004, pp 1-21.
33. Guazzi MD, Agostoni P, Perego B et al. Apparent paradox of neurohumoral axis inhibition after fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 1994; 72: 534-539.
34. Costanzo MR, Guglin ME, Saltzberg MT, et al., UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683.